LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing,9,10-seco- cyclopentanohydrophenanthrene ring system doai

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

1 .alpha.-hydroxy-25-ene-vitamin D, analogs and uses thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

1α-Hydroxyvitamin D5, its synthesis and use in cancer...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

1&agr;-hydroxy-2-methylene-19-nor-homopregnacalciferol and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

1&agr;-hydroxy-2-methylene-19-nor-homopregnacalciferol and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

1,25-Dihydroxy-24-oxo-vitamin D.sub.3 and 1,23,25-trihydroxy-24-

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

1,3-dihydroxy-20,20-cycloalkyl-vitamin D3analogs

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

1.alpha.,24-(OH).sub.2 -cholecalciferol emulsion composition and

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

1.alpha.,25-dihydroxy-26,27-dimethylcholecalciferol and its use

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

1.alpha.-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

1.alpha.-hydroxy vitamin D.sub.4 and novel intermediates and ana

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

16-ene-26,27-bishomo cholecalciferols

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

17,20(E)-dehydro vitamin D analogs and their uses

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

17,20(E)-dehydro vitamin D analogs and their uses

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

17,20(Z)-dehydro vitamin D analogs and their uses

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

17-ene vitamine D analogues

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

18, 19-Dinor-vitamin D compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

18,19-dinor-vitamin D compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

18,19-dinor-vitamin D compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

18-nor-vitamin D compounds